Dashboard
Manage Tickers

ENLVEnlivex Therapeutics Ltd.

Nasdaq enlivex.com


$ 1.27 $ 0.03 (2.52 %)    

Thursday, 08-Aug-2024 15:59:21 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 449.23 $ 13.30 (3.06 %)
DIA $ 395.05 $ 6.75 (1.74 %)
SPY $ 531.28 $ 11.99 (2.31 %)
TLT $ 95.30 $ -0.59 (-0.62 %)
GLD $ 224.00 $ 3.46 (1.57 %)
$ 1.261
$ 1.26 x 200
$ 1.30 x 257
-- - --
$ 1.15 - $ 4.59
48,003
na
23.45M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enlivex-receives-israeli-ministry-of-health-authorization-for-the-initiation-of-a-phase-i-clinical-trial-to-evaluate-allocetra-in-patients-with-psoriatic-arthritis
Enlivex Receives Israeli Ministry Of Healt...
07/23/2024 12:08:32

enlivex-doses-first-patient-in-a-randomized-placebo-controlled-phase-iii-trial-evaluating-allocetratm-in-up-to-46-patients-with-thumb-osteoarthritis
Enlivex Doses First Patient In A Randomize...
06/24/2024 12:07:54

First patient dosed with AllocetraTM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects...

enlivex-therapeutics-releases-interim-data-readout-from-phase-iii-allocetratm-trial-showing-three-month-readout-showed-avg-pain-reduciotn-of-64-33-of-patients-reported-pain-resolution-89-of-patients-did-not-proceed-with-knee-replacement-surgery
Enlivex Therapeutics Releases Interim Data...
06/17/2024 12:05:06

hc-wainwright--co-maintains-buy-on-enlivex-therapeutics-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on Enliv...
06/11/2024 10:13:44

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and lowers the pr...

enlivex-receives-regulatory-authorization-for-the-initiation-of-a-placebo-controlled-phase-iii-trial-evaluating-allocetra-in-up-to-46-patients-with-thumb-osteoarthritis
Enlivex Receives Regulatory Authorization ...
06/03/2024 12:43:12

 First study of AllocetraTM in thumb osteoarthritis, a debilitating disease that affects millions of people in the U.S., and ha...

enlivex-therapeutics-enters-agreement-for-registered-direct-offering-of-357m-ordinary-shares-and-milestone-linked-warrants-raising-5m-upfront-and-up-to-10m-from-warrant-exercises
Enlivex Therapeutics Enters Agreement For ...
05/28/2024 12:14:50

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

hc-wainwright--co-reiterates-buy-on-enlivex-therapeutics-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Enli...
04/23/2024 10:33:34

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and maintains $7...

enlivex-announces-dosing-of-first-two-patients-in-its-randomized-controlled-phase-iii-trial-evaluating-allocetra-in-patients-with-knee-osteoarthritis
Enlivex Announces Dosing Of First Two Pati...
04/22/2024 12:05:03

 Enlivex Therapeutics Ltd. (NASDAQ:ENLV, the "Company")))), a clinical-stage macrophage reprogramming immunotherapy com...

enlivex-announces-authorization-from-danish-medicines-agency-for-a-randomized-controlled-phase-iii-trial-evaluating-allocetra-in-patients-with-knee-osteoarthritis
Enlivex Announces Authorization From Danis...
04/16/2024 11:57:13

tesla-to-180-here-are-10-top-analyst-forecasts-for-friday
Tesla To $180? Here Are 10 Top Analyst For...
04/12/2024 13:07:48

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

hc-wainwright--co-maintains-buy-on-enlivex-therapeutics-lowers-price-target-to-7
HC Wainwright & Co. Maintains Buy on Enliv...
04/12/2024 10:43:19

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and lowers the pr...

nasdaq-jumps-250-points-crude-oil-down-1
Nasdaq Jumps 250 Points; Crude Oil Down 1%
04/11/2024 19:21:09

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...

why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Fastenal Shares Are Trading Lower By A...
04/11/2024 17:33:07

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

dow-dips-100-points-carmax-earnings-miss-views
Dow Dips 100 Points; CarMax Earnings Miss ...
04/11/2024 15:55:35

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

nasdaq-gains-over-50-points-us-producer-prices-increase-in-march
Nasdaq Gains Over 50 Points; US Producer P...
04/11/2024 13:41:48

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the D...

enlivex-announces-topline-results-of-its-phase-ii-trial-evaluating-allocetra-in-patients-with-sepsis
Enlivex Announces Topline Results Of Its P...
04/11/2024 12:18:17

Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the saf...

enlivex-receives-regulatory-authorization-from-israels-health-ministry-for-initiation-of-phase-12-trial-evaluating-allocetra-in-patients-with-knee-osteoarthritis
Enlivex Receives Regulatory Authorization ...
02/26/2024 13:36:22

enlivex-completes-enrollment-of-120-patients-in-phase-2-trial-of-allocetra-in-patients-with-sepsis
Enlivex Completes Enrollment Of 120 Patien...
02/21/2024 13:35:10

enlivex-announces-issuance-of-new-us-patent-number-us-11883429-covering-allocetra-cells-and-their-manufacturing-method
Enlivex Announces Issuance Of New U.S. Pat...
02/07/2024 13:01:42

Enlivex Therapeutics Ltd., (NASDAQ:ENLV, the "Company")))), a clinical-stage macrophage reprogramming immunotherapy com...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION